 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - QVT Fund V LP
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2018-04-02 Purchase | 2018-04-04 4:29 pm | Myovant Sciences Ltd. | MYOV | QVT Associates GP LLC QVT Fund V LP Director 10% Owner | 1,110,015 | $20.27 | $22,500,005 | 38,341,356 (Indirect) | View |
| 2018-06-05 Purchase | 2018-06-07 08:38 am | Axovant Sciences Ltd. | AXON | QVT Associates GP LLC QVT Fund V LP 10% Owner | 14,285,714 | $1.75 | $25,000,000 | 89,285,712 (Indirect) | View |
| 2018-10-01 Purchase | 2018-10-03 5:50 pm | Urovant Sciences Ltd. | UROV | QVT Associates GP LLC QVT Fund V LP 10% Owner | 2,678,571 | $14 | $37,499,994 | 22,703,668 (Indirect) | View |
| 2019-06-04 Purchase | 2019-06-06 8:05 pm | Myovant Sciences Ltd. | MYOV | QVT Associates GP LLC QVT Fund V LP 10% Owner | 2,424,242 | $8.25 | $19,999,997 | 40,765,600 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2017-10-16 Purchase | 2017-10-17 09:16 am | N/A 2021-10-16 | Arbutus Biopharma Corp | ABUS | QVT Associates GP LLC QVT Fund V LP Director 10% Owner | 500,000 | $100 | 500,000 (Indirect) | View |
| 2018-01-12 Purchase | 2018-01-16 08:40 am | N/A 2021-10-16 | Arbutus Biopharma Corp | ABUS | QVT Associates GP LLC QVT Fund V LP Director 10% Owner | 664,000 | $100 | 1,164,000 (Indirect) | View |